Polen Capital Kodiak Sciences Inc. Transaction History
Polen Capital Management LLC
- $30.8 Billion
- Q3 2025
A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Polen Capital Management LLC holds 21,567 shares of KOD stock, worth $420,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,567Holding current value
$420,772% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KOD
# of Institutions
128Shares Held
44.4MCall Options Held
125KPut Options Held
133K-
Baker Bros. Advisors LP New York, NY17.3MShares$338 Million2.31% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$75.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.84MShares$55.4 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$38.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.34MShares$26 Million0.04% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $1.02B
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...